Tiletamine and zolazepam for injection contains a wider margin of safety in cats than in canine. Canine have survived recurring IM dosage regimens of 13.6 mg/lb (30 mg/kg) (optimum Harmless dose) for eight successive days. This can be approximately two times the most advised therapeutic dose.If this SPL is made up of inactivated NDCs detailed by t